Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 placeSee list

Cognition Therapeutics Inc (CGTX)

NASDAQ
Currency in USD
Disclaimer
0.400
-0.009(-2.30%)
Real-time Data
CGTX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Trading near 52-week Low
Fair Value
Day's Range
0.3480.409
52 wk Range
0.3482.950
Prev. Close
0.409
Open
0.409
Day's Range
0.348-0.409
52 wk Range
0.348-2.95
Volume
195,535
Average Volume (3m)
1,096,791
1-Year Change
-67.02%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
CGTX Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
6.500
Upside
+1,525.000%
Members' Sentiments
Bearish
Bullish
ProTips
4 analysts have revised their earnings upwards for the upcoming period
Show more

Cognition Therapeutics Company Profile

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to the S2R complex, which is in Phase 2 clinical trial for the treatment of Alzheimer’s disease, as well as geographic atrophy secondary to dry age-related macular degeneration and synucleinopathies, such as dementia with Lewy bodies. The company was incorporated in 2007 and is headquartered in Purchase, New York.

Compare CGTX to Peers and Sector

Metrics to compare
CGTX
Peers
Sector
Relationship
P/E Ratio
−0.5x−1.0x−0.6x
PEG Ratio
0.050.000.00
Price/Book
0.7x1.7x2.6x
Price / LTM Sales
-3.0x3.2x
Upside (Analyst Target)
-230.4%48.5%
Fair Value Upside
Unlock17.8%7.8%Unlock

FAQ

What Is the Cognition Therapeutics (CGTX) Stock Price Today?

The Cognition Therapeutics stock price today is 0.40.

What Stock Exchange Does Cognition Therapeutics Trade On?

Cognition Therapeutics is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Cognition Therapeutics?

The stock symbol for Cognition Therapeutics is "CGTX."

What Is the Cognition Therapeutics Market Cap?

As of today, Cognition Therapeutics market cap is 16.41M.

What is Cognition Therapeutics Earnings Per Share?

The Cognition Therapeutics EPS is -0.92.

What Is the Next Cognition Therapeutics Earnings Date?

Cognition Therapeutics will release its next earnings report on 12 Nov 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.